Clinical Trials Logo

Clinical Trial Summary

The goal of this research study is to test the feasibility and preliminary efficacy of using a virtual reality (VR) psychosocial intervention for improving quality of life and psychological distress in patients hospitalized for bone marrow transplantation (BMT). Participants will be randomly assigned into one of the study groups: the virtual reality psychosocial intervention (BMT-VR) + usual care versus usual care alone. The BMT-VR intervention has several components: 1. Psychoeducation to enhance preparedness, manage expectations, and mobilize social supports. 2. Psychosocial skill building to promote effective coping and facilitate acceptance while living with uncertainty of treatment outcomes. 3. Self-care to promote effective coping and enhance patient's sense of control as they transition from inpatient to outpatient care


Clinical Trial Description

Patients undergoing BMT endure substantial physical and psychological symptoms during a prolonged hospitalization with significant risk of complications, which negatively impact their overall quality of life. There is a critical need to develop innovative supportive care interventions to improve the quality of life and care of patients undergoing BMT. This is a single-center, randomized, controlled research study to test the feasibility and preliminary efficacy of BMT-VR for improving quality of life and reducing psychological stress for patients undergoing BMT. BMT-VR is a self-administered virtual reality psychosocial intervention to address the supportive care needs of patients undergoing BMT. Participants will be recruited and randomized in 1:1 fashion to BMT-VR + usual care versus usual care alone, stratified by transplant type (autologous vs. allogenic BMT) Participants randomly assigned to BMT-VR group will receive usual transplant care by their BMT team and will also be given a virtual reality headset to engage with BMT-VR during their BMT hospitalization. Participants will complete six sections focused on educating them about BMT and helping them manage the physical and emotional symptoms with the BMT process. Participants randomly assigned to the usual care group will receive usual transplant care by their BMT team and will not be given access to the BMT-VR intervention. In both groups, participants are asked to complete questionnaires (in-person, over the computer or telephone, or by mail) at baseline, 2, 4, 12, and 24 weeks after enrolling in the study. It is expected about 80 participants will take part in this study. Rocket VR Health, Inc. is supporting this research study by providing funding. ;


Study Design


Related Conditions & MeSH terms

  • Bone Marrow Transplant Complications

NCT number NCT05629676
Study type Interventional
Source Massachusetts General Hospital
Contact Areej El-Jawahri, MD
Phone 617-724-4000
Email ael-jawahri@partners.org
Status Recruiting
Phase N/A
Start date December 20, 2022
Completion date December 30, 2026

See also
  Status Clinical Trial Phase
Recruiting NCT05611307 - Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors
Recruiting NCT03818334 - Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological Malignancies Phase 2/Phase 3
Withdrawn NCT05895201 - High-Dose Post-Transplant Cyclophosphamide, Bortezomib, and Sitagliptin for the Prevention of GVHD Phase 1/Phase 2
Completed NCT04687982 - Feasibility and Efficacy of Modified Donor Lymphocytes Infusion (CD45RA Negative Selected) After Haploidentical Transplantation With Post-transplantation Cyclophosphamide in Patients With Hematological Malignancies (ONC-2016-002). N/A
Recruiting NCT06416761 - Genetics in the Progression of Nephropathies
Completed NCT03858530 - Ultrasound Elastography to Predict Development of SOS Phase 4
Recruiting NCT04313036 - 5-day Defibrotide Treatment for Hepatic SOS/VOD Phase 2
Completed NCT03200626 - Observational Study to Evaluate Hematopoietic Progenitor Cell Mobilization in Patients With Newly Diagnosed Multiple Myeloma
Recruiting NCT05709912 - Mobile CARE-App to Promote Coping for Caregivers of Patients Receiving Stem Cell Transplant N/A
Completed NCT05175222 - Assessment of Efficacy of LightWalker (Nd:Yag, Er:Yag) Laser Therapy on Incidence, Severity and Duration of Oral Mucositis in Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT). Prospective Randomized Open-label Study N/A
Recruiting NCT05316740 - Vaginal Microbiome and the Development of Vulvovaginal Graft Versus Host Disease
Recruiting NCT05694910 - Reiki Effects on Bone Marrow Transplant Patients N/A
Completed NCT05352789 - Nutrition and Metabolic Prehabilitation in HSCT Patients UK and ROI. BSBMT Multi-centre Survey.
Withdrawn NCT03963999 - Validating Ultrasound Biomarkers for Hepatic Sinusoidal Obstruction Syndrome in Pediatric Hematopoietic Cell Transplant Patients Phase 4
Recruiting NCT03865589 - Using Ultrasound Elastography to Predict Development of Hepatic Sinusoidal Obstruction Syndrome N/A